Noaber Ventures

Alba Health is a company focused on enhancing children's gut health through digital solutions and advanced microbiome testing. It offers an innovative stool test kit designed for easy use, allowing parents to analyze their child's gut microbiome in a certified laboratory. Upon completion of the analysis, detailed results are provided, which enable parents to collaborate with dieticians in formulating personalized action plans for their children's dietary and health needs. Additionally, Alba Health places significant emphasis on data privacy by anonymizing test results, which can contribute to broader discoveries that positively influence children's health outcomes. The company's overarching mission is to improve the health of future generations by leveraging artificial intelligence and microbiome science.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.

Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions. The company has developed a hyper-personalized engagement platform designed to enhance clinical outcomes for individuals with chronic conditions. This platform offers tailored recommendations that consider the right timing, tone, and real-world context, guiding patients throughout their health journey. By catering to the specific needs of patients, Sweetch enables pharmaceutical companies, device manufacturers, payers, and healthcare providers to establish continuous relationships and effectively engage with each individual at scale.

Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

NewCompliance is a healthcare technology company focused on enhancing the quality and safety of medical care through innovative solutions. The company collaborates with industry leaders such as Stryker, Medtronic, Skytron, and Philips to provide interoperable IT platforms. Its flagship product, the ACTIQ platform, delivers predictive dashboarding and analytics, offering real-time feedback and intelligent management information to healthcare providers. This web-based software is designed to support caregivers across various departments, including surgery, emergency care, and intensive care. By optimizing safety, efficiency, and patient satisfaction, NewCompliance aims to transform the surgical patient journey and improve overall healthcare delivery.

LeQuest B.V., founded in 2011 and based in Rotterdam, the Netherlands, specializes in e-training services for the healthcare industry. The company has developed a software platform that enables healthcare professionals to receive training on the use of complex medical equipment. This platform includes several modules that digitally reproduce medical devices and their functionalities. As the healthcare sector increasingly relies on advanced medical technology, LeQuest's software assists healthcare institutions in managing staff competencies and knowledge. The platform ensures that certification, registration, and retraining for specific medical equipment are systematically addressed, enhancing the overall proficiency of healthcare professionals.

Ambient Clinical Analytics, Inc. is a healthcare technology company specializing in data assimilation, communication, and analytics for clinical decision support. Based in Rochester, Minnesota, the company develops tools tailored for use in intensive care units, operating rooms, and emergency departments. Its flagship product, AWARE, integrates with various electronic health record systems and bedside monitors to deliver critical patient information on a unified dashboard. Additionally, Ambient offers the Mayo Clinic YES Board, a multi-patient management tool that enhances situational awareness and streamlines patient flow. The company also provides specialized solutions such as Sepsis DART for real-time sepsis detection and the Ventilator-Induced Lung Injury Sniffer for monitoring ventilator patients. Furthermore, the Synthesis Platform serves as an integration hub for AWARE and the Mayo Clinic tools, facilitating seamless data exchange. Ambient Clinical Analytics was founded in 2013 and focuses on improving patient outcomes while reducing healthcare costs through innovative technology.

LeQuest B.V., founded in 2011 and based in Rotterdam, the Netherlands, specializes in e-training services for the healthcare industry. The company has developed a software platform that enables healthcare professionals to receive training on the use of complex medical equipment. This platform includes several modules that digitally reproduce medical devices and their functionalities. As the healthcare sector increasingly relies on advanced medical technology, LeQuest's software assists healthcare institutions in managing staff competencies and knowledge. The platform ensures that certification, registration, and retraining for specific medical equipment are systematically addressed, enhancing the overall proficiency of healthcare professionals.

Noona Healthcare Oy, established in 2014 and headquartered in Helsinki, Finland, specializes in developing a Web-based mobile service called Noona. This platform enables breast cancer patients to directly report treatment-related symptoms to their clinics via mobile phones, tablets, and computers, fostering real-time, holistic patient monitoring. Additionally, Noona's platform facilitates scientific research by generating digital data that combines patient diagnosis, treatment, and genetic information, aiding in the development of new cancer therapies. As of 2018, Noona Healthcare operates as a subsidiary of Varian Medical Systems, Inc.

Institute for Positive Health (iPH) is the driving force behind the Positive Health movement. The foundation was founded by Machteld Huber, the founder of the philosophy. The institute wants to stimulate, strengthen and accelerate the movement that has arisen around Positive Health. For example, together we make the Netherlands the largest Blue Zone in the world, a place where people live longer, healthier and happier than anywhere else in the world.

EarlySense Ltd. is a developer of advanced patient monitoring systems tailored for hospitals, healthcare systems, integrated delivery networks, and rehabilitation centers. Founded in 2004 and based in Ramat Gan, Israel, with additional offices in Woburn, Massachusetts, the company specializes in signal-processing technology that enhances patient safety and facilitates early detection of health deterioration. Its flagship product, the EarlySense System, offers continuous monitoring of heart rate, respiratory rate, and patient motion, allowing clinical teams to manage risks such as falls and pressure ulcers. Additionally, the Central Display Station enables nursing staff to supervise patients effectively, while the contact-free consumer health monitor, known as LIVE, provides users and caregivers with insights into heart health, breathing cycles, and sleep quality. The company's offerings, including EarlySense Live, cater to a variety of healthcare environments and are distributed in Israel, the United States, and Australia. EarlySense has established a strategic partnership with Welch Allyn to further enhance its product capabilities.

The welfare state makes way for a society with its own responsibility and active participation in social life. The focus is on quality of life rather than on limitations or illness. The share of collectively funded healthcare is getting smaller. Own direction and freedom of choice are paramount. Care and support are more often organized in their own environment: with family, neighbors, a (social) network or a purchasing collective. Innovation and quality improvement As a network organization, Fundis responds flexibly to the ever-changing (care) demand. Fundis is continuously expanding, keeping up-to-date or improving the care and service offering and business operations. Fundis does not do this alone. With existing companies within the Fundis group, by adding new companies to the group or by working intensively with partners outside the group. Everything with the aim of providing high-quality care and services for health and well-being to frail elderly and chronically ill people.

EarlySense Ltd. is a developer of advanced patient monitoring systems tailored for hospitals, healthcare systems, integrated delivery networks, and rehabilitation centers. Founded in 2004 and based in Ramat Gan, Israel, with additional offices in Woburn, Massachusetts, the company specializes in signal-processing technology that enhances patient safety and facilitates early detection of health deterioration. Its flagship product, the EarlySense System, offers continuous monitoring of heart rate, respiratory rate, and patient motion, allowing clinical teams to manage risks such as falls and pressure ulcers. Additionally, the Central Display Station enables nursing staff to supervise patients effectively, while the contact-free consumer health monitor, known as LIVE, provides users and caregivers with insights into heart health, breathing cycles, and sleep quality. The company's offerings, including EarlySense Live, cater to a variety of healthcare environments and are distributed in Israel, the United States, and Australia. EarlySense has established a strategic partnership with Welch Allyn to further enhance its product capabilities.

& NIPED is an E-health platform based in Amsterdam, Netherlands, founded in 2005. The company offers a patented knowledge platform designed to facilitate personal health management within healthcare systems. This platform enables users to create and monitor a personalized health profile through a secure online account, incorporating biometrics and laboratory research for a comprehensive view of their health. Based on this profile, users receive tailored referrals for medical, psychological, and lifestyle interventions. The platform includes a complete range of stepped-care intervention options, ensuring that users find the best match for their health needs. & NIPED has developed various prevention applications, such as Preventiekompas and Persoonlijke Gezondheidscheck, which provide self-health monitoring services through online questionnaires that assess lifestyle, mental, physical, and familial factors, ultimately empowering users to maintain a healthy lifestyle.

Alba Health is a company focused on enhancing children's gut health through digital solutions and advanced microbiome testing. It offers an innovative stool test kit designed for easy use, allowing parents to analyze their child's gut microbiome in a certified laboratory. Upon completion of the analysis, detailed results are provided, which enable parents to collaborate with dieticians in formulating personalized action plans for their children's dietary and health needs. Additionally, Alba Health places significant emphasis on data privacy by anonymizing test results, which can contribute to broader discoveries that positively influence children's health outcomes. The company's overarching mission is to improve the health of future generations by leveraging artificial intelligence and microbiome science.